{
  "id": "somatic-hypermutation",
  "title": "Somatic Hypermutation",
  "lang": "en",
  "source_lang": "en",
  "summary": "Somatic hypermutation introduces mutations into antibody genes in activated B cells, supplying variation for affinity maturation.",
  "category": "science",
  "subcategory": "biology",
  "type": "concept",
  "aliases": [
    "SHM",
    "Immunoglobulin somatic hypermutation"
  ],
  "generated_at": "2026-10-04",
  "model": "pro/gpt-6.1-sol",
  "url": "https://aiwiki.page/en/somatic-hypermutation/",
  "translations": {
    "zh-Hans": {
      "url": "https://aiwiki.page/zh/somatic-hypermutation/",
      "json": "https://aiwiki.page/zh/somatic-hypermutation.json"
    }
  },
  "sections": [
    {
      "heading": "",
      "text": "Somatic hypermutation (SHM) is a regulated process that introduces unusually frequent mutations into the DNA encoding the variable regions of antibodies in activated B cells. It generates related cells with different antigen-binding properties, providing variation on which selection acts during affinity maturation. A central mechanism of adaptive immunity, SHM depends on activation-induced cytidine deaminase and the mutagenic processing of DNA lesions. Mutation itself does not necessarily improve antibody binding; improvement emerges through subsequent selection. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Biological setting and targets",
      "text": "In mammals, SHM is strongly associated with the germinal centers that develop in secondary lymphoid organs during immune responses. Germinal-center B cells undergo repeated cycles of proliferation, mutation, and selection. Their surface immunoglobulins provide a means of testing the binding properties of newly generated variants against antigen. Descendants of a single responding B cell can therefore acquire distinct antibody sequences while remaining members of the same clonal lineage. (pmc.ncbi.nlm.nih.gov)\n\nThe principal antibody targets are the rearranged variable-region genes of immunoglobulin heavy and light chains, together with nearby transcribed sequences. SHM predominantly produces single-base substitutions, although insertions and deletions also occur. Frequently cited mutation rates are approximately 10⁻⁴–10⁻³ substitutions per base per cell generation, substantially above ordinary background mutation rates. These estimates describe targeted regions under particular experimental conditions rather than a uniform rate across the genome. (pmc.ncbi.nlm.nih.gov)\n\n“Somatic” distinguishes these changes from inherited germline variation. They diversify the responding B-cell lineage rather than altering the inherited antibody-gene repertoire of the organism’s offspring. Within the variable region, substitutions may change amino acids involved in antigen recognition or affect the structural framework supporting the binding site. (pmc.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Initiation by cytidine deamination",
      "text": "The initiating enzyme is activation-induced cytidine deaminase (AID), encoded by AICDA. Experiments reported in 2000 established that AID-deficient mice fail to carry out normal SHM and immunoglobulin class switching. Subsequent biochemical experiments demonstrated that AID converts cytosine to uracil in single-stranded DNA, establishing a direct route from its enzymatic activity to antibody-gene diversification. (pubmed.ncbi.nlm.nih.gov)\n\nAID requires accessible single-stranded DNA rather than an intact double helix. Transcription helps create suitable substrates, and antibody hypermutation is concentrated within a limited region downstream of transcriptional control elements. Deamination converts an ordinary cytosine–guanine pair into a uracil–guanine mismatch. This lesion is the starting point for several alternative processing pathways, not a completed mutation in every case. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Mutagenic processing of DNA lesions",
      "text": "SHM repurposes components of DNA repair, allowing lesions to generate sequence diversity rather than always restoring the original sequence. The outcome depends partly on how the uracil–guanine mismatch is handled:\n\n- Replication across uracil: During DNA replication, uracil can template adenine, fixing a cytosine-to-thymine transition or its complementary guanine-to-adenine change.\n- Uracil removal: Uracil-DNA glycosylase (UNG), associated with base excision repair, removes uracil and leaves an abasic site. Error-prone copying or processing of that site can generate additional substitutions at the original cytosine–guanine pair.\n- Mismatch-directed processing: The MSH2–MSH6 complex of DNA mismatch repair recognizes the mismatch. Excision and mutagenic resynthesis can extend sequence changes to neighboring adenine–thymine pairs. (pmc.ncbi.nlm.nih.gov)\n\nDNA polymerase η is particularly important for mutations at adenine–thymine pairs. Biochemical experiments demonstrated physical and functional interactions between this polymerase and MSH2–MSH6. Studies of human B-cell repertoires with defects in UNG or mismatch-repair proteins likewise reveal characteristic changes in mutation spectra. These pathways interact; they are not completely independent routes with identical contributions in every setting. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Sequence bias and affinity selection",
      "text": "SHM is stochastic but not sequence-uniform. Mutations preferentially occur at hotspot motifs such as WRCY and its reverse complement RGYW, where W denotes A or T, R denotes A or G, and Y denotes C or T. Local nucleotide context and the enzymes processing lesions influence which substitutions arise. Hotspots create mutational biases, but they do not instruct the system to produce a particular beneficial antibody. (pmc.ncbi.nlm.nih.gov)\n\nSelection is a separate cellular process. In the germinal-center light zone, B cells capture antigen and present derived peptides through major histocompatibility complex class II molecules. T follicular helper cells, a specialized T-cell population, provide signals that favor expansion of selected B cells. Experimental manipulation of antigen presentation shows that greater access to T-cell help can increase both subsequent cell division and accumulated hypermutation. (pubmed.ncbi.nlm.nih.gov)\n\nMutation and selection therefore form an iterative process: variants arise, their binding and presentation properties affect competitive success, and selected cells undergo further expansion. This process can also produce antibody-secreting plasma cells and memory B cells, although these output populations need not represent identical selections of the evolving repertoire. (pmc.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Relationship to other diversification mechanisms",
      "text": "SHM differs from V(D)J recombination, which assembles variable-region gene segments during early B-cell development. SHM instead modifies already rearranged antibody sequences. It also differs from class-switch recombination, which changes the heavy-chain constant region and thereby antibody effector properties. SHM and class switching both require AID, but they act on different regions and produce different genetic outcomes. (pubmed.ncbi.nlm.nih.gov)"
    },
    {
      "heading": "Experimental and disease relevance",
      "text": "DNA sequencing allows researchers to compare mutated immunoglobulin sequences with inferred germline sequences, examine substitution patterns, and reconstruct clonal relationships. Human genetic defects provide complementary evidence: AID deficiency disrupts SHM and class switching, while defects in lesion-processing proteins can alter which mutations are produced. (pmc.ncbi.nlm.nih.gov)\n\nAID activity is not absolutely restricted to immunoglobulin genes. Genome-wide experimental mapping has identified non-immunoglobulin targets in germinal-center B cells. Such off-target damage helps explain why the targeting and processing of AID lesions are relevant to the genetic abnormalities associated with B-cell lymphomas. Normal antibody diversification and potentially harmful mutagenesis thus share an initiating enzymatic activity, although their biological outcomes differ. (rupress.org)"
    }
  ],
  "links": [
    "mutation",
    "dna",
    "antibody",
    "b-cell",
    "affinity-maturation",
    "adaptive-immunity",
    "germinal-center",
    "antigen",
    "gene",
    "genome",
    "amino-acid",
    "enzyme",
    "transcription-biology",
    "dna-repair",
    "dna-replication",
    "base-excision-repair",
    "dna-mismatch-repair",
    "dna-polymerase",
    "nucleotide",
    "major-histocompatibility-complex",
    "t-cell",
    "cell-division",
    "plasma-cell",
    "memory-b-cell",
    "vdj-recombination",
    "class-switch-recombination",
    "dna-sequencing",
    "lymphoma"
  ],
  "sources": [
    {
      "title": "pubmed.ncbi.nlm.nih.gov/11007474/",
      "url": "https://pubmed.ncbi.nlm.nih.gov/11007474/"
    },
    {
      "title": "pmc.ncbi.nlm.nih.gov/articles/PMC2191212/",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2191212/"
    },
    {
      "title": "pmc.ncbi.nlm.nih.gov/articles/PMC1276717/",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC1276717/"
    },
    {
      "title": "pubmed.ncbi.nlm.nih.gov/12756266/",
      "url": "https://pubmed.ncbi.nlm.nih.gov/12756266/"
    },
    {
      "title": "pmc.ncbi.nlm.nih.gov/articles/PMC2738296/",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC2738296/"
    },
    {
      "title": "pubmed.ncbi.nlm.nih.gov/15710654/",
      "url": "https://pubmed.ncbi.nlm.nih.gov/15710654/"
    },
    {
      "title": "pubmed.ncbi.nlm.nih.gov/25170154/",
      "url": "https://pubmed.ncbi.nlm.nih.gov/25170154/"
    },
    {
      "title": "pmc.ncbi.nlm.nih.gov/articles/PMC4271732/",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC4271732/"
    },
    {
      "title": "pmc.ncbi.nlm.nih.gov/articles/PMC6718458/",
      "url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC6718458/"
    },
    {
      "title": "rupress.org/jem/article/215/3/761/42580/A-broad-atlas-of-somatic-hypermutation-…",
      "url": "https://rupress.org/jem/article/215/3/761/42580/A-broad-atlas-of-somatic-hypermutation-allows"
    }
  ],
  "license": "https://creativecommons.org/licenses/by/4.0/"
}